| ALT Snapshot | |
|---|---|
| Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland. | |
| VALUATION DATA | |
| Market Capitalization | $529,588,000 | Price to Sales | 1.00 |
| Earnings per Share | $-1.6600 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $7.5700 |
| 52 Week High | $1329.7 |
| 52 Week Low | $2.918 |
| 50-Day Moving Average | $866.92 |
| 200-Day Moving Average | $-4.2 |
| All data are from Alpha Vantage as of today. For more infomation on ALT see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search